Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : CTI-005
Therapeutic Area : Infections and Infectious Diseases
Study Phase : IND Enabling
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : CTI-005 are nanoparticles made of human red blood cell membranes. Leveraging the natural receptors on the red blood cell membranes, CTI-005 can neutralize toxins secreted by MRSA or MSSA bacteria and thus enable the innate human immune system to kill the...
Product Name : CTI-005
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
March 05, 2022
Lead Product(s) : CTI-005
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : IND Enabling
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
